SINO BIOPHARM News

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF CATEGORY 1 INNVOATIVE DRUG UNECRITNIB FUMARATE CAPSULES "UNECRITINIB (TQ-B3101)"

Apr 30 04:31 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - 52 RESEARCH RESULTS WILL BE PRESENTED AT 2024 ASCO ANNUAL MEETING

Apr 29 10:42 ET

SINO BIOPHARM: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS

Apr 29 04:50 ET

SINO BIOPHARM: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS

Apr 29 04:48 ET

SINO BIOPHARM: FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)

Apr 29 04:46 ET

SINO BIOPHARM: NOTICE OF ANNUAL GENERAL MEETING

Apr 29 04:45 ET

SINO BIOPHARM: GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; RE-ELECTION OF DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING

Apr 29 04:44 ET

SINO BIOPHARM: 2023 ANNUAL REPORT

Apr 29 04:42 ET

SINO BIOPHARM: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 29 04:28 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - CATEGORY 1 INNOVATIVE DRUG "TQA3038 (siRNA)" COMPLETED PHASE I CLINICAL STUDY

Apr 25 06:03 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

Apr 19 06:09 ET

SINO BIOPHARM: NEXT DAY DISCLOSURE RETURN

Apr 19 05:02 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - CATEGORY 1 INNOVATIVE DRUG "ROVADICITINIB (TQ05105)" OBTAINED POSITIVE RESULTS IN KEY CLINICAL RESEARCH FOR REGISTRATION

Apr 18 07:27 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

Apr 17 05:09 ET

SINO BIOPHARM: NEXT DAY DISCLOSURE RETURN

Apr 16 04:35 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

Apr 15 04:59 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

Apr 12 05:22 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - PRESENTATION OF THE PHASE II CLINICAL STUDY DATA ON KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)"

Apr 10 18:04 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - DATA OF 6 STUDIES REGARDING "ANLOTINIB HYDROCHLORIDE CAPSULES", "TQB2916 (CD40 AGONIST)" AND "FHND6091 (PROTEASOME INHIBITOR)" WERE PRESENTED AT 2024 AACR

Apr 10 08:02 ET

SINO BIOPHARM: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME

Apr 8 05:52 ET